OVERVIEW OF ANTIMICROBIAL STEWARDSHIP

OVERVIEW OF
ANTIMICROBIAL STEWARDSHIP
DR TANVEER REHMAN
SCIENTIST – B (MEDICAL)
PUBLIC HEALTH DIVISION
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 2
Background
• Global Action Plan on Antimicrobial Resistance (AMR)
• Overuse and misuse of antimicrobials as a main driver for development of AMR
• Optimize the use of antimicrobial medicines in human and animal health
• Practical guidance on how to implement antimicrobial stewardship (AMS)
programmes in the human health sector at health-care facility
• Improve patient outcomes, reduce AMR and health-care-associated infections,
and save health-care costs amongst others
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 3
Antimicrobial stewardship
• Careful and responsible management of something entrusted to one’s care
• Applied in the health-care setting as a tool for optimizing antimicrobial use
• One of three “pillars” of an integrated approach to health system strengthening
• Infection prevention and control (IPC) and medicine and patient safety
• WHO essential medicines list (EML) AWaRe classification
• Promotes equitable and quality health care towards the goal of achieving
universal health coverage (UHC)
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 4
‘Access’ Group – WHO ‘AWaRe’
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 5
‘WAtch’ Group – WHO ‘AWaRe’
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 6
‘REserve’ Group – WHO ‘AWaRe’
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 7
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 8
Aim of AMS
• Optimize the use of antibiotics
• Promote behaviour change in antibiotic prescribing and dispensing practices
• Improve quality of care and patient outcomes
• Save on unnecessary health-care costs
• Reduce further emergence, selection and spread of AMR
• Prolong the lifespan of existing antibiotics
• Build the best-practices capacity of health-care professionals
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 9
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 10
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 11
Antimicrobial prescribing facts
• 30% of all hospitalised in-patient at any given time receive antibiotics
• About 50% of antimicrobial use has been found to be inappropriate
• Up to 30% of all surgical prophylaxis is inappropriate
• URTI – reason for the 75% of the antibiotic prescriptions each year; in most
cases of URTIs, antibiotic confers little or no benefit
• 10-30% of antimicrobial cost can be saved by AMS
• Globally, dentists were reported to prescribe up to 11.3 % of all antibiotics.
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 12
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 13
Prospective (real-time) audit with feedback
• Prospective audit with feedback (e.g. on ward rounds) involves the assessment
of antibiotic therapy by AMS team, who make recommendations to prescribers
in real time when therapy is considered suboptimal.
• It may be performed alongside clinical personnel on ward rounds, providing
oral recommendations for changes in antibiotic treatment in real time.
• Alternatively, AMS team may perform ward rounds on their own, providing
written recommendations for changes in antibiotic treatment
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 14
Formulary restriction/preauthorization
• Use of restricted antibiotics may be limited to certain indications, prescribers,
services, patient populations or a combination of these.
• Selection of restricted antibiotics is done by facility authorities, the AMS team
and heads of units based on spectrum, cost or toxicities.
• Antibiotics are restricted before use; ensures expert approval before initiation
• Practical approach that allows attending physician to use the drug pending
approval by physician or AMS team after +/− 48 hours
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 15
Didactic education
• Formal or informal teaching to engage prescribers in improving antibiotic
prescribing, dispensing and administration practices
• Clinical case discussions, classes, reminders, conference presentations, student
and house staff teaching sessions, provision of written guidelines,
informational pamphlets, posters or e-mail alert – STG/ updates
• Education alone, without incorporation of active intervention is only
marginally effective
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 16
Streamlining/de-escalation
• All clinicians should perform a review of antibiotics 48 hours after prescription
• When microbiological results become available, antibiotic treatment should be
streamlined accordingly: choose the most active antibiotic(s) with least
toxicity, narrowest spectrum and lowest cost
• De-escalation is safe for sepsis and septic shock, and is associated with
decreased mortality
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 17
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 18
Outcome measures
• Outcome measures/indicators related to antimicrobial use
DDD or DOTS per 100(0) patient-days: Defined Daily Dose of an agent from
pharmacy dispensing or health-care facility purchasing data or Days of Therapy
from nursing chart administrative data (paper) in a period of time
• Outcome measures/ indicators related to patients and microbiology
In-hospital mortality, Length of stay, Readmission within 30 days after discharge
Clostridium difficile: Number of health-care-associated C. difficile infections
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 19
Common areas for improving antibiotic prescribing
• Overprescribing: when not needed, e.g. fever without evidence of infection,
viral infections, malaria, asymptomatic urinary tract colonization
• Overly broad spectrum: More broad-spectrum antibiotics (WATCH and
RESERVE) are prescribed than are necessary (e.g. surgical prophylaxis)
• Unnecessary combination therapy, including certain FDC: Multiple antibiotics
are used, particularly with overlapping spectra and in combinations that have
not been shown to improve clinical outcomes.
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 20
Common areas for improving antibiotic prescribing
• Wrong antibiotic choice: Wrong antibiotic(s) are prescribed for particular
indications/infections.
• Wrong dose: Over- or under dosing
• Wrong dose interval: Antibiotics are prescribed with the wrong dose interval
(too much time between doses).
• Wrong route: Antibiotics are prescribed by the wrong route (e.g. IV instead of
oral).
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 21
What can the individual physicians do
• Obtain appropriate cultures before starting antibiotic
• Review antibiotic use after 48 – 72 hours : does it need to be continued?
• Stop antibiotic in patient with alternative non-infectious diagnosis
• Optimize dosing and duration of antibiotic therapy
• Avoid unnecessary use, especially in viral upper respiratory tract infections
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 22
Health-care facility AMS team
• Implements day-to-day AMS activities like conducting regular ward rounds
• Undertakes audits or PPSs to assess the appropriateness of antibiotic prescription
• Monitors, analyses and interprets the quantity and types of antibiotic use at the
unit and/or facility-wide level
• Monitors antibiotic susceptibility and resistance rates for a range of key indicator
bacteria at the facility-wide level or uses the data from existing groups
• Facilitates education and training on AMS in the facility.
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 23
Health-care facility AMS team
Option 1: >2 : physician, a pharmacist, a nurse with expertise in infections or IPC,
and in facilities with a microbiology laboratory, a microbiologist
Option 2: a physician and a nurse or pharmacist, with access to expert advice
Option 3: an AMS champion, e.g. a physician, nurse or pharmacist leading the
stewardship programme, with access to expert advice (e.g. secondary or small
facilities with limited resources).
• Frequency of meetings: Weekly to two times a month
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 24
THANK YOU
25/09/2023 AMS Dr Tanveer Rehman RMRCBB 25
References
1. ICMR. Antimicrobial Stewardship Program Guideline
2. Antimicrobial stewardship programmes in health-care facilities in low-and middle-income
countries: a WHO practical toolkit
3. Vijay S, Ramasubramanian V, Bansal N, Ohri VC, Walia K. Hospital-based antimicrobial
stewardship, India. Bulletin of the World Health Organization. 2023
1 de 25

Recomendados

Antibiotic policy introduction by Dr.T.V.Rao MD por
Antibiotic policy introduction by Dr.T.V.Rao MD Antibiotic policy introduction by Dr.T.V.Rao MD
Antibiotic policy introduction by Dr.T.V.Rao MD Society for Microbiology and Infection care
2.6K visualizações32 slides
Antimicrobial stewardship por
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardshipDr. Sohini Banerjee
230 visualizações22 slides
Efflax pumps por
Efflax pumpsEfflax pumps
Efflax pumpsmahsajalili1993
232 visualizações43 slides
Infection Control and Antibiotic resistance por
Infection Control and Antibiotic resistanceInfection Control and Antibiotic resistance
Infection Control and Antibiotic resistanceMoustapha Ramadan
3.8K visualizações30 slides
Laboratory detection of resistant bacteria por
Laboratory detection of resistant bacteriaLaboratory detection of resistant bacteria
Laboratory detection of resistant bacteriaMostafa Mahmoud
6.3K visualizações45 slides

Mais conteúdo relacionado

Mais procurados

Antimicrobial stewardship por
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardshipAbhijit Chaudhury
4K visualizações59 slides
Antimicrobial stewardship CME 04-03-19 por
Antimicrobial stewardship CME 04-03-19Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19Tahseen Siddiqui
809 visualizações32 slides
Dr. Lonnie King - Keynote - One Health Approach to Antimicrobial Resistance a... por
Dr. Lonnie King - Keynote - One Health Approach to Antimicrobial Resistance a...Dr. Lonnie King - Keynote - One Health Approach to Antimicrobial Resistance a...
Dr. Lonnie King - Keynote - One Health Approach to Antimicrobial Resistance a...John Blue
1.3K visualizações48 slides
Antimicrobial stewardship methodology and metrics for slideshare por
Antimicrobial stewardship methodology and metrics for slideshareAntimicrobial stewardship methodology and metrics for slideshare
Antimicrobial stewardship methodology and metrics for slidesharedrakmane
864 visualizações55 slides
Antibiotic policy por
Antibiotic policyAntibiotic policy
Antibiotic policyDr. Md Ashraf Ali Namaji
18.7K visualizações73 slides
The new β lactamases por
The new β lactamasesThe new β lactamases
The new β lactamasesNeha Sharma
3.5K visualizações25 slides

Mais procurados(20)

Antimicrobial stewardship por Abhijit Chaudhury
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardship
Abhijit Chaudhury4K visualizações
Antimicrobial stewardship CME 04-03-19 por Tahseen Siddiqui
Antimicrobial stewardship CME 04-03-19Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19
Tahseen Siddiqui809 visualizações
Dr. Lonnie King - Keynote - One Health Approach to Antimicrobial Resistance a... por John Blue
Dr. Lonnie King - Keynote - One Health Approach to Antimicrobial Resistance a...Dr. Lonnie King - Keynote - One Health Approach to Antimicrobial Resistance a...
Dr. Lonnie King - Keynote - One Health Approach to Antimicrobial Resistance a...
John Blue1.3K visualizações
Antimicrobial stewardship methodology and metrics for slideshare por drakmane
Antimicrobial stewardship methodology and metrics for slideshareAntimicrobial stewardship methodology and metrics for slideshare
Antimicrobial stewardship methodology and metrics for slideshare
drakmane864 visualizações
The new β lactamases por Neha Sharma
The new β lactamasesThe new β lactamases
The new β lactamases
Neha Sharma3.5K visualizações
antitubercular drug susceptibility testing por Malathi Murugesan
antitubercular drug susceptibility testingantitubercular drug susceptibility testing
antitubercular drug susceptibility testing
Malathi Murugesan6K visualizações
Antibiotic policy por wisam alsaedi
Antibiotic policyAntibiotic policy
Antibiotic policy
wisam alsaedi562 visualizações
Extended Spectrum Beta Lactamases Esbl por Temujin Chavez
Extended Spectrum Beta Lactamases EsblExtended Spectrum Beta Lactamases Esbl
Extended Spectrum Beta Lactamases Esbl
Temujin Chavez7K visualizações
IDSA Practice Guidelines for Antimicrobial Stewardship Programs por Joy Awoniyi
IDSA Practice Guidelines for Antimicrobial Stewardship ProgramsIDSA Practice Guidelines for Antimicrobial Stewardship Programs
IDSA Practice Guidelines for Antimicrobial Stewardship Programs
Joy Awoniyi16.8K visualizações
Amp C (1).pptx por Rasika Deshmukh
Amp C (1).pptxAmp C (1).pptx
Amp C (1).pptx
Rasika Deshmukh371 visualizações
Antimicrobial resistance por NAIF AL SAGLAN
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance
NAIF AL SAGLAN2.3K visualizações
Antimicrobial stewardship por Mohd Saif Khan
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardship
Mohd Saif Khan10K visualizações
Amp C por Prenesh
Amp CAmp C
Amp C
Prenesh 3K visualizações
Laboratory diagnosis of_infectious_diseases por Shilpa k
Laboratory diagnosis of_infectious_diseasesLaboratory diagnosis of_infectious_diseases
Laboratory diagnosis of_infectious_diseases
Shilpa k13.2K visualizações
An tibiotic policy in medical care seminar por deepak deshkar
An tibiotic policy in medical care seminarAn tibiotic policy in medical care seminar
An tibiotic policy in medical care seminar
deepak deshkar270 visualizações
Recent advances in tuberculosis por Dr Amit Vatkar
Recent advances in tuberculosisRecent advances in tuberculosis
Recent advances in tuberculosis
Dr Amit Vatkar2.2K visualizações
Rabies vaccine ppt by royal por husnatazeen
Rabies vaccine ppt by royalRabies vaccine ppt by royal
Rabies vaccine ppt by royal
husnatazeen6.1K visualizações

Similar a OVERVIEW OF ANTIMICROBIAL STEWARDSHIP

Antimicrobial stewardship.pptx por
Antimicrobial stewardship.pptxAntimicrobial stewardship.pptx
Antimicrobial stewardship.pptxJosephMalinda1
12 visualizações25 slides
Antimicrobial Stewardship por
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial StewardshipFatmaAtef10
202 visualizações66 slides
AMSP PPT.pptx por
AMSP PPT.pptxAMSP PPT.pptx
AMSP PPT.pptxDrmayuribhise
119 visualizações51 slides
Asp antimicrobial stewardship por
Asp antimicrobial stewardshipAsp antimicrobial stewardship
Asp antimicrobial stewardshipMEEQAT HOSPITAL
1.1K visualizações25 slides
Antibiotic Stewardship Program.pptx por
Antibiotic Stewardship Program.pptxAntibiotic Stewardship Program.pptx
Antibiotic Stewardship Program.pptxsunnysingh906052
1K visualizações25 slides
AB policy.pptx por
AB policy.pptxAB policy.pptx
AB policy.pptxAhmedMandour37
14 visualizações26 slides

Similar a OVERVIEW OF ANTIMICROBIAL STEWARDSHIP(20)

Antimicrobial stewardship.pptx por JosephMalinda1
Antimicrobial stewardship.pptxAntimicrobial stewardship.pptx
Antimicrobial stewardship.pptx
JosephMalinda112 visualizações
Antimicrobial Stewardship por FatmaAtef10
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial Stewardship
FatmaAtef10202 visualizações
AMSP PPT.pptx por Drmayuribhise
AMSP PPT.pptxAMSP PPT.pptx
AMSP PPT.pptx
Drmayuribhise119 visualizações
Asp antimicrobial stewardship por MEEQAT HOSPITAL
Asp antimicrobial stewardshipAsp antimicrobial stewardship
Asp antimicrobial stewardship
MEEQAT HOSPITAL1.1K visualizações
Antibiotic Stewardship Program.pptx por sunnysingh906052
Antibiotic Stewardship Program.pptxAntibiotic Stewardship Program.pptx
Antibiotic Stewardship Program.pptx
sunnysingh9060521K visualizações
AB policy.pptx por AhmedMandour37
AB policy.pptxAB policy.pptx
AB policy.pptx
AhmedMandour3714 visualizações
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptx por Chinmoy Sahu
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptxAntimicrobial Stewardship_Dr Chinmoy Sahu.pptx
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptx
Chinmoy Sahu25 visualizações
CDC-core-elements.pdf por ssuser9f80d7
CDC-core-elements.pdfCDC-core-elements.pdf
CDC-core-elements.pdf
ssuser9f80d711 visualizações
Antibiotic Policy.pdf por AhmedSamir462624
Antibiotic Policy.pdfAntibiotic Policy.pdf
Antibiotic Policy.pdf
AhmedSamir46262427 visualizações
Judicious use of antibiotics por Massimo Sartelli
Judicious use of antibioticsJudicious use of antibiotics
Judicious use of antibiotics
Massimo Sartelli684 visualizações
Guidelines for rational use of antibiotics in surgical prophylaxis por DrLakshmiGayathripha
Guidelines for rational use of antibiotics in surgical prophylaxisGuidelines for rational use of antibiotics in surgical prophylaxis
Guidelines for rational use of antibiotics in surgical prophylaxis
DrLakshmiGayathripha5.4K visualizações
guidelinesforantibiotics-200827064818.pdf por SridharA50
guidelinesforantibiotics-200827064818.pdfguidelinesforantibiotics-200827064818.pdf
guidelinesforantibiotics-200827064818.pdf
SridharA5011 visualizações
Who antibiotic policy iihmr jaipur por Ashish Gupta
Who antibiotic policy iihmr jaipurWho antibiotic policy iihmr jaipur
Who antibiotic policy iihmr jaipur
Ashish Gupta386 visualizações
Antibiotic policy por Dr Chinmay Dash
Antibiotic policyAntibiotic policy
Antibiotic policy
Dr Chinmay Dash1.1K visualizações
4. Evolving Roles of Pharmacists in AMS by Dr. Mediadora Saniel.pdf por MarkAnthonyEllana1
4. Evolving Roles of Pharmacists in AMS by Dr. Mediadora Saniel.pdf4. Evolving Roles of Pharmacists in AMS by Dr. Mediadora Saniel.pdf
4. Evolving Roles of Pharmacists in AMS by Dr. Mediadora Saniel.pdf
MarkAnthonyEllana1105 visualizações
Antibiotic Policy - An Overview por Sourabh Mandwariya
Antibiotic Policy - An OverviewAntibiotic Policy - An Overview
Antibiotic Policy - An Overview
Sourabh Mandwariya513 visualizações
Dr. Jeff Bender - Companion Animal Antimicrobial Stewardship por John Blue
Dr. Jeff Bender - Companion Animal Antimicrobial StewardshipDr. Jeff Bender - Companion Animal Antimicrobial Stewardship
Dr. Jeff Bender - Companion Animal Antimicrobial Stewardship
John Blue1.6K visualizações
ANTIBIOTIC POLICY.pptx por Monishabasavaraj
ANTIBIOTIC POLICY.pptxANTIBIOTIC POLICY.pptx
ANTIBIOTIC POLICY.pptx
Monishabasavaraj38 visualizações

Mais de TanveerRehman4

Validity & reliability of screening & diagnostic tests por
Validity & reliability of screening & diagnostic testsValidity & reliability of screening & diagnostic tests
Validity & reliability of screening & diagnostic testsTanveerRehman4
1.3K visualizações40 slides
MCH Care Indicators por
MCH Care IndicatorsMCH Care Indicators
MCH Care IndicatorsTanveerRehman4
15.7K visualizações27 slides
Indicators_demographic & fertility_practical class por
Indicators_demographic & fertility_practical classIndicators_demographic & fertility_practical class
Indicators_demographic & fertility_practical classTanveerRehman4
291 visualizações27 slides
Disease prevention strategies: Primary por
Disease prevention strategies: PrimaryDisease prevention strategies: Primary
Disease prevention strategies: PrimaryTanveerRehman4
835 visualizações17 slides
Approach to Neck and Back Pain por
Approach to Neck and Back PainApproach to Neck and Back Pain
Approach to Neck and Back PainTanveerRehman4
265 visualizações22 slides
District level bodies por
District level bodiesDistrict level bodies
District level bodiesTanveerRehman4
504 visualizações14 slides

Mais de TanveerRehman4(20)

Validity & reliability of screening & diagnostic tests por TanveerRehman4
Validity & reliability of screening & diagnostic testsValidity & reliability of screening & diagnostic tests
Validity & reliability of screening & diagnostic tests
TanveerRehman41.3K visualizações
MCH Care Indicators por TanveerRehman4
MCH Care IndicatorsMCH Care Indicators
MCH Care Indicators
TanveerRehman415.7K visualizações
Indicators_demographic & fertility_practical class por TanveerRehman4
Indicators_demographic & fertility_practical classIndicators_demographic & fertility_practical class
Indicators_demographic & fertility_practical class
TanveerRehman4291 visualizações
Disease prevention strategies: Primary por TanveerRehman4
Disease prevention strategies: PrimaryDisease prevention strategies: Primary
Disease prevention strategies: Primary
TanveerRehman4835 visualizações
Approach to Neck and Back Pain por TanveerRehman4
Approach to Neck and Back PainApproach to Neck and Back Pain
Approach to Neck and Back Pain
TanveerRehman4265 visualizações
District level bodies por TanveerRehman4
District level bodiesDistrict level bodies
District level bodies
TanveerRehman4504 visualizações
Healthcare delivery - State level por TanveerRehman4
Healthcare delivery - State levelHealthcare delivery - State level
Healthcare delivery - State level
TanveerRehman41.3K visualizações
Public health disciplines por TanveerRehman4
Public health disciplinesPublic health disciplines
Public health disciplines
TanveerRehman4292 visualizações
Public health planning in India por TanveerRehman4
Public health planning in IndiaPublic health planning in India
Public health planning in India
TanveerRehman4204 visualizações
Water borne diseases (bacterial) por TanveerRehman4
Water borne diseases (bacterial)Water borne diseases (bacterial)
Water borne diseases (bacterial)
TanveerRehman4949 visualizações
Developing counter strategy for Information warfare in Health Sector – siftin... por TanveerRehman4
Developing counter strategy for Information warfare in Health Sector – siftin...Developing counter strategy for Information warfare in Health Sector – siftin...
Developing counter strategy for Information warfare in Health Sector – siftin...
TanveerRehman423 visualizações
Medical Entomology Part II por TanveerRehman4
Medical Entomology Part IIMedical Entomology Part II
Medical Entomology Part II
TanveerRehman456 visualizações
Surveillance and contact tracing por TanveerRehman4
Surveillance and contact tracingSurveillance and contact tracing
Surveillance and contact tracing
TanveerRehman4517 visualizações
Team building por TanveerRehman4
Team buildingTeam building
Team building
TanveerRehman4454 visualizações
Diabetes Mellitus por TanveerRehman4
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
TanveerRehman473 visualizações
STATA - Basics of Analysis & Commands por TanveerRehman4
STATA - Basics of Analysis & CommandsSTATA - Basics of Analysis & Commands
STATA - Basics of Analysis & Commands
TanveerRehman4220 visualizações
Studies in health economics por TanveerRehman4
Studies in health economicsStudies in health economics
Studies in health economics
TanveerRehman4517 visualizações
RNTCP Changes in 2018 por TanveerRehman4
RNTCP Changes in 2018RNTCP Changes in 2018
RNTCP Changes in 2018
TanveerRehman4131 visualizações
Nipah virus por TanveerRehman4
Nipah virusNipah virus
Nipah virus
TanveerRehman4256 visualizações
Ayushman bharat scheme por TanveerRehman4
Ayushman bharat schemeAyushman bharat scheme
Ayushman bharat scheme
TanveerRehman48.1K visualizações

Último

Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends por
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness TrendsTop Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trendsmuskansbl01
59 visualizações15 slides
Biomedicine & Pharmacotherapy por
Biomedicine & PharmacotherapyBiomedicine & Pharmacotherapy
Biomedicine & PharmacotherapyTrustlife
220 visualizações12 slides
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx por
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptxICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptxABG
65 visualizações45 slides
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx por
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptxINTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptxABG
120 visualizações40 slides
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP por
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPMohamadAlhes
89 visualizações28 slides
Myocardial Infarction Nursing.pptx por
Myocardial Infarction Nursing.pptxMyocardial Infarction Nursing.pptx
Myocardial Infarction Nursing.pptxAsraf Hussain
22 visualizações73 slides

Último(20)

Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends por muskansbl01
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness TrendsTop Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
muskansbl0159 visualizações
Biomedicine & Pharmacotherapy por Trustlife
Biomedicine & PharmacotherapyBiomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy
Trustlife220 visualizações
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx por ABG
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptxICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ABG65 visualizações
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx por ABG
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptxINTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx
ABG120 visualizações
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP por MohamadAlhes
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
MohamadAlhes89 visualizações
Myocardial Infarction Nursing.pptx por Asraf Hussain
Myocardial Infarction Nursing.pptxMyocardial Infarction Nursing.pptx
Myocardial Infarction Nursing.pptx
Asraf Hussain22 visualizações
communication and nurse patient relationship by Tamanya Samui.pdf por TamanyaSamui1
communication and nurse patient relationship by Tamanya Samui.pdfcommunication and nurse patient relationship by Tamanya Samui.pdf
communication and nurse patient relationship by Tamanya Samui.pdf
TamanyaSamui133 visualizações
Impact of ICF on collaboration and communication por Olaf Kraus de Camargo
Impact of ICF on collaboration and communicationImpact of ICF on collaboration and communication
Impact of ICF on collaboration and communication
Olaf Kraus de Camargo27 visualizações
Quit Smoking Revolution.pdf por Gio Ferrandino
Quit Smoking Revolution.pdfQuit Smoking Revolution.pdf
Quit Smoking Revolution.pdf
Gio Ferrandino26 visualizações
Correct handling of laboratory Rats ppt.pptx por TusharChaudhary99
Correct handling of laboratory Rats ppt.pptxCorrect handling of laboratory Rats ppt.pptx
Correct handling of laboratory Rats ppt.pptx
TusharChaudhary9932 visualizações
Buccoadhesive drug delivery System.pptx por ABG
Buccoadhesive drug delivery System.pptxBuccoadhesive drug delivery System.pptx
Buccoadhesive drug delivery System.pptx
ABG167 visualizações
Thrives Priority Areas: Behavioral Health por City of Chesapeake
Thrives Priority Areas: Behavioral HealthThrives Priority Areas: Behavioral Health
Thrives Priority Areas: Behavioral Health
City of Chesapeake93 visualizações
The Art of naming drugs.pptx por DanaKarem1
The Art of naming drugs.pptxThe Art of naming drugs.pptx
The Art of naming drugs.pptx
DanaKarem125 visualizações
vitamin c.pptx por ajithkilpart
vitamin c.pptxvitamin c.pptx
vitamin c.pptx
ajithkilpart19 visualizações
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl... por DipeshGamare
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...
DipeshGamare18 visualizações
Explore new Frontiers in Medicine with AI.pdf por Anne Marie
Explore new Frontiers in Medicine with AI.pdfExplore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdf
Anne Marie18 visualizações
Vyadhikshmatva.pptx 1.pptx por Akshay Shetty
Vyadhikshmatva.pptx 1.pptxVyadhikshmatva.pptx 1.pptx
Vyadhikshmatva.pptx 1.pptx
Akshay Shetty53 visualizações

OVERVIEW OF ANTIMICROBIAL STEWARDSHIP

  • 1. OVERVIEW OF ANTIMICROBIAL STEWARDSHIP DR TANVEER REHMAN SCIENTIST – B (MEDICAL) PUBLIC HEALTH DIVISION
  • 2. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 2
  • 3. Background • Global Action Plan on Antimicrobial Resistance (AMR) • Overuse and misuse of antimicrobials as a main driver for development of AMR • Optimize the use of antimicrobial medicines in human and animal health • Practical guidance on how to implement antimicrobial stewardship (AMS) programmes in the human health sector at health-care facility • Improve patient outcomes, reduce AMR and health-care-associated infections, and save health-care costs amongst others 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 3
  • 4. Antimicrobial stewardship • Careful and responsible management of something entrusted to one’s care • Applied in the health-care setting as a tool for optimizing antimicrobial use • One of three “pillars” of an integrated approach to health system strengthening • Infection prevention and control (IPC) and medicine and patient safety • WHO essential medicines list (EML) AWaRe classification • Promotes equitable and quality health care towards the goal of achieving universal health coverage (UHC) 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 4
  • 5. ‘Access’ Group – WHO ‘AWaRe’ 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 5
  • 6. ‘WAtch’ Group – WHO ‘AWaRe’ 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 6
  • 7. ‘REserve’ Group – WHO ‘AWaRe’ 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 7
  • 8. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 8
  • 9. Aim of AMS • Optimize the use of antibiotics • Promote behaviour change in antibiotic prescribing and dispensing practices • Improve quality of care and patient outcomes • Save on unnecessary health-care costs • Reduce further emergence, selection and spread of AMR • Prolong the lifespan of existing antibiotics • Build the best-practices capacity of health-care professionals 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 9
  • 10. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 10
  • 11. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 11
  • 12. Antimicrobial prescribing facts • 30% of all hospitalised in-patient at any given time receive antibiotics • About 50% of antimicrobial use has been found to be inappropriate • Up to 30% of all surgical prophylaxis is inappropriate • URTI – reason for the 75% of the antibiotic prescriptions each year; in most cases of URTIs, antibiotic confers little or no benefit • 10-30% of antimicrobial cost can be saved by AMS • Globally, dentists were reported to prescribe up to 11.3 % of all antibiotics. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 12
  • 13. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 13
  • 14. Prospective (real-time) audit with feedback • Prospective audit with feedback (e.g. on ward rounds) involves the assessment of antibiotic therapy by AMS team, who make recommendations to prescribers in real time when therapy is considered suboptimal. • It may be performed alongside clinical personnel on ward rounds, providing oral recommendations for changes in antibiotic treatment in real time. • Alternatively, AMS team may perform ward rounds on their own, providing written recommendations for changes in antibiotic treatment 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 14
  • 15. Formulary restriction/preauthorization • Use of restricted antibiotics may be limited to certain indications, prescribers, services, patient populations or a combination of these. • Selection of restricted antibiotics is done by facility authorities, the AMS team and heads of units based on spectrum, cost or toxicities. • Antibiotics are restricted before use; ensures expert approval before initiation • Practical approach that allows attending physician to use the drug pending approval by physician or AMS team after +/− 48 hours 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 15
  • 16. Didactic education • Formal or informal teaching to engage prescribers in improving antibiotic prescribing, dispensing and administration practices • Clinical case discussions, classes, reminders, conference presentations, student and house staff teaching sessions, provision of written guidelines, informational pamphlets, posters or e-mail alert – STG/ updates • Education alone, without incorporation of active intervention is only marginally effective 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 16
  • 17. Streamlining/de-escalation • All clinicians should perform a review of antibiotics 48 hours after prescription • When microbiological results become available, antibiotic treatment should be streamlined accordingly: choose the most active antibiotic(s) with least toxicity, narrowest spectrum and lowest cost • De-escalation is safe for sepsis and septic shock, and is associated with decreased mortality 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 17
  • 18. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 18
  • 19. Outcome measures • Outcome measures/indicators related to antimicrobial use DDD or DOTS per 100(0) patient-days: Defined Daily Dose of an agent from pharmacy dispensing or health-care facility purchasing data or Days of Therapy from nursing chart administrative data (paper) in a period of time • Outcome measures/ indicators related to patients and microbiology In-hospital mortality, Length of stay, Readmission within 30 days after discharge Clostridium difficile: Number of health-care-associated C. difficile infections 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 19
  • 20. Common areas for improving antibiotic prescribing • Overprescribing: when not needed, e.g. fever without evidence of infection, viral infections, malaria, asymptomatic urinary tract colonization • Overly broad spectrum: More broad-spectrum antibiotics (WATCH and RESERVE) are prescribed than are necessary (e.g. surgical prophylaxis) • Unnecessary combination therapy, including certain FDC: Multiple antibiotics are used, particularly with overlapping spectra and in combinations that have not been shown to improve clinical outcomes. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 20
  • 21. Common areas for improving antibiotic prescribing • Wrong antibiotic choice: Wrong antibiotic(s) are prescribed for particular indications/infections. • Wrong dose: Over- or under dosing • Wrong dose interval: Antibiotics are prescribed with the wrong dose interval (too much time between doses). • Wrong route: Antibiotics are prescribed by the wrong route (e.g. IV instead of oral). 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 21
  • 22. What can the individual physicians do • Obtain appropriate cultures before starting antibiotic • Review antibiotic use after 48 – 72 hours : does it need to be continued? • Stop antibiotic in patient with alternative non-infectious diagnosis • Optimize dosing and duration of antibiotic therapy • Avoid unnecessary use, especially in viral upper respiratory tract infections 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 22
  • 23. Health-care facility AMS team • Implements day-to-day AMS activities like conducting regular ward rounds • Undertakes audits or PPSs to assess the appropriateness of antibiotic prescription • Monitors, analyses and interprets the quantity and types of antibiotic use at the unit and/or facility-wide level • Monitors antibiotic susceptibility and resistance rates for a range of key indicator bacteria at the facility-wide level or uses the data from existing groups • Facilitates education and training on AMS in the facility. 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 23
  • 24. Health-care facility AMS team Option 1: >2 : physician, a pharmacist, a nurse with expertise in infections or IPC, and in facilities with a microbiology laboratory, a microbiologist Option 2: a physician and a nurse or pharmacist, with access to expert advice Option 3: an AMS champion, e.g. a physician, nurse or pharmacist leading the stewardship programme, with access to expert advice (e.g. secondary or small facilities with limited resources). • Frequency of meetings: Weekly to two times a month 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 24
  • 25. THANK YOU 25/09/2023 AMS Dr Tanveer Rehman RMRCBB 25 References 1. ICMR. Antimicrobial Stewardship Program Guideline 2. Antimicrobial stewardship programmes in health-care facilities in low-and middle-income countries: a WHO practical toolkit 3. Vijay S, Ramasubramanian V, Bansal N, Ohri VC, Walia K. Hospital-based antimicrobial stewardship, India. Bulletin of the World Health Organization. 2023